Search results for ' Biocon' - ReePrime

ReePrime

Results for " Biocon"

Videos

Biocon Campus Vandalised ET NOW

Biocon: Budget 2017 Wishlist NDTV Profit

Steady Q4 For Biocon NDTV Profit

Interview: Biocon MD, Kiran Mazumdar Shaw Mint

Strong Quarter For Biocon NDTV Profit

Biocon Plays The Biosimilars Card NDTV Profit

Biocon Expects Recovery From April NDTV Profit

Health Check On Biocon NDTV Profit

Biocon on Q3 earnings performance CNBC-TV18

U.S. FDA Inspection Reveals Lapses At Biocon NDTV Profit

Biocon Q3FY20 earnings: What to expect? CNBC-TV18

Stocks in news Dalmia Bharat, Biocon ET NOW

Biocon Inks Deal With Novartis NDTV Profit

Stocks To Watch: Biocon, Mphasis & ITC NDTV Profit

Biocon Withdraws Drug Application With EMA NDTV Profit

Analysts Fail to Predict Biocon Rally NDTV Profit

Drug price control unilateral, rationale puzzling: Biocon ET NOW

Buy Biocon, SBI, IVRCL: Sandeep Wagle ET NOW

Brijesh Bhatia's Technical View On Biocon NDTV Profit

Biocon Q4 Net up by 250%, EBITDA down 21% ET NOW

ET Now Exclusive - Biocon downplays Statin fears ET NOW

India's Biocon on Generic GLP-1 Push Bloomberg

Biocon Gets Thumbs Up From Raja Venkatraman NDTV Profit

Biocon Q3 earnings: Expect a strong performance CNBC-TV18

Biocon & Mylan Launch Cancer Drug In U.S. NDTV Profit

Biocon Jumps On FDA's Letter On Mylan's Biosimilar NDTV Profit

Biocon Q1 earnings today: Here’s what to expect CNBC-TV18

Kiran Mazumdar Shaw Chairman of Biocon India Pushyunreliable

Kiran Mazumdar : Pfizer and Biocon have amicable separation ET NOW

Biocon, Novartis & Pfizer: Buy, Hold Or Sell? #AskBQ NDTV Profit

Biocon Outlook On The Biosimilar Sales | NDTV Profit NDTV Profit

Stocks in News: Biocon, Rel Comm, Tata Tele ET NOW

Biocon Biologics CEO Discusses Merger and IPO Plans Bloomberg

ETNOW Exclusive - Why Biocon - Pfizer deal failed ET NOW

Stocks in news: Biocon, Sequent, Tata Motors ET NOW

Buy Biocon, Rolta, sell Asian Paints: Mitesh Thacker ET NOW

Biocon Gets A Thumbs-Up From Two Regulators NDTV Profit

Kiran Mazumdar Shaw of Biocon on business outlook CNBC-TV18

Biocon Q4FY19 numbers: Expect strong earnings momentum to continue CNBC-TV18

Buy BOI, Tech Mah, Sun Pharma, Biocon: Experts ET NOW

Biocon Has Time Till December For Cancer Drug NDTV Profit

Biocon, Novartis & Pfizer: Buy, Hold Or Sell? #AskBQ NDTV Profit

Sensex, Nifty open in green; Biocon, Wockhardt down ET NOW

Biocon Q3 meets estimates, business grew by 23% ET NOW

US drugmaker Pfizer scraps insulin deal with Biocon ET NOW

Bullish on Biocon, May See a Correction: Porinju NDTV Profit

Kiran Mazumdar Shaw of Biocon on biosimilar & business outlook CNBC-TV18

Analysts Discuss Biocon, Talwalkars, Apex Frozen & Other Stocks NDTV Profit

Q1 Review | What Worked, What Didn't For Biocon NDTV Profit

Biocon Rallies On FDA's Letter On Mylan's Biosimilar NDTV Profit

Loading more videos...